Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FY22H
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of August 14, 2025. The delivery order is for EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and pain management applications. This award was issued without a set-aside designation, allowing the vendor to compete on an open basis. The contract represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance with the DLA, securing numerous delivery orders for an extensive portfolio of medications and medical consumables ranging from prescription drugs and biologics to specialty pharmaceutical products and medical devices. The company's federal procurement track record demonstrates its capability to reliably distribute branded and generic pharmaceuticals, vaccines, and specialized medical products to military health facilities across the United States and internationally, making it an integral partner in supporting the Department of Defense's medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FY22H?
SPE2DB25FY22H was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FY22H worth?
The government has obligated $5,021 on SPE2DB25FY22H.
Is contract SPE2DB25FY22H an order under another contract?
Yes. SPE2DB25FY22H is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22H competed?
The extent of competition for SPE2DB25FY22H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award